ANAnna Nießen

Anna Nießen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anna Nießen has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Two-stage anastomotic reconstruction after pancreatectomy (TARP procedure) – A single-center retrospective case series

    by Faik G. Uzunoglu, Victoria van Rüth, Fiete Gehrisch, Mara R. Götz, Kira Meißner, Anna Nießen, Felix Nickel, Thilo Hackert


  • Rektale neuroendokrine Tumoren des Rektums: Update endoskopische und chirurgische Therapie

    by Feline Ockenga, Alina S. Ritter, Thomas Rösch, Thilo Hackert, Anna Nießen

    Rectal neuroendocrine tumors (rNET) are rare but increasingly more common entities, which are usually an incidental finding during routine colonoscopy. The rNETs are usually well-differentiated with low metastatic potential. Thus, staging is only required in high-risk situations (size ≥ 10 mm, invasion of the muscularis propria, grading > G1, L1, V1). Endoscopic resection is the most frequently used treatment. Based on the depth of invasion, endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD) or endoscopic full-thickness resection (EFTR) are applied. In cases of R1 resection, re-endoscopic resection can be conducted to achieve R0 status. Radical surgical resection with higher or lower anterior rectum (HAR/LAR) resection with total mesorectal excision (TME) is indicated for rNETs > 20 mm, rNETs between 10-20 mm with risk factors (R1 resection after second endoscopic resection, Ki67 > 10%, L1, V1), lymph node metastasis and also in cases of distant metastasis if those are also resectable. In cases of unresectable distant metastasis, systemic treatment is applied. The prognosis after treatment of well-differentiated rNETs is generally favorable.

  • Open Access

    Minimally Invasive Resection of Occult Insulinomas—Experience from an ENETS Centre of Excellence and Review of the Literature

    by Alina S. Ritter, Feline Ockenga, Kira C. Steinkraus, Jelte Poppinga, Philipp H. von Kroge, Tania Amin, Fabrice Viol, Thorben W. Fründt, Felix Nickel, Thilo Hackert, et al.

    Background/Objectives: Insulinomas are rare insulin-secreting pancreatic neuroendocrine tumours (pNETs). Preoperative tumour localisation can usually be achieved by computed tomography (CT), magnetic resonance imaging, or positron emission tomography (PET)-CT. However, cross-sectional imaging can be negative, defining an insulinoma as occult and thus hampering surgical resection. Methods: All patients who underwent minimally invasive (MI) surgery for an insulinoma at the University Medical Center Hamburg-Eppendorf since 2017 were analysed. Clinicopathological parameters and diagnostic and operative approaches were assessed. A literature search of the MI resection of occult insulinomas was conducted. Results: Of eight patients with MI-resected insulinomas, two (25%) had negative preoperative imaging. Mean tumour size was 17.2 ± 13.3 mm. Patients underwent distal pancreatectomy (DP), enucleation, and pancreatic head resection (PHR) in 62.5% (5/8), 25.0% (2/8), and 12.5% (1/8) of cases, respectively. One patient had a major postoperative complication (Clavien–Dindo ≥ 3a). Twenty-four studies reporting on 140 occult insulinomas were identified. Occult insulinomas were more frequent in females, often located in the distal pancreas and G1-differentiated. Glucagon-Like Peptide-1 Receptor/PET-CT most frequently localised the conventionally non-visible insulinomas (positive in 67/76, 88.2%). Enucleation, DP, PHR and other resections were conducted in 47/94 (50.0%), 40/94 (42.6%), 4/94 (4.3%), and 3 (3.2%) of the reported cases. MI resection was reported in 10 of 19 (52.6%) specified resections. Conclusions: Insulinomas can be undetectable in cross-sectional and functional imaging. Surgical exploration with intraoperative ultrasound should be considered when clinical presentation and biochemical findings are highly suggestive for insulinoma. Minimally invasive and parenchyma sparing resection is feasible even for occult insulinomas and should always be considered.


  • Surgery of early-stage pancreatic cancer

    by Jelte Poppinga, Alina S. Ritter, Kira C. Steinkraus, Anna Nießen, Thilo Hackert

    Background Pancreatic cancer (PDAC) remains one of the most lethal malignancies, with early detection and surgical resection being the only potentially curative treatment option. Despite advancements in diagnostics and surgical techniques, the prognosis of early-stage PDAC remains poor. Understanding the indications, approaches and perioperative management is crucial for improving patient survival. Summary Surgical resection remains the only curative treatment for early-stage PDAC. Different surgical procedures are performed depending on tumor location and local extent. Advances in minimally invasive surgery (MIS) yielded promising results regarding postoperative recovery and oncologic outcomes. The implementation of neoadjuvant therapy has improved resection and survival rates. Still, pancreatic surgery is associated with significant morbidity. Key Messages • Surgical resection remains the only curative option for early-stage pancreatic cancer. • Neoadjuvant chemotherapy plays a crucial role in improving resection and survival rates. • Perioperative care has been refined by MIS, optimized surgical techniques and structured complication management.


  • Open Access

    Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours

    by Alina S. Ritter, Jelte Poppinga, Kira C. Steinkraus, Thilo Hackert, Anna Nießen

    Purpose of Review: Neuroendocrine tumours (NET) are rare entities arising from hormone producing cells in the gastroentero-pancreatic (GEP) tract. Surgery is the most common treatment of GEP-NETs. Recent Findings: Improvements in surgical techniques allow for more locally advanced and metastasised GEP-NETs to be resected. Laparoscopic and robotically--assisted approaches are increasingly being utilised in the resection of selected GEP-NETs and are facilitated by novel intraoperative tumour localisation tools and parenchyma-sparing methods. At the same time, some authors suggest that indications for formal resections of small well differentiated non-functioning pancreatic NETs and appendiceal NETs should be more restrictive. Summary: Advancements in surgery allows for tissue-sparing resections of GEP-NETs. Indications for surgical resection and the extent of the procedure are highly dependent on GEP-NET size, localisation and grading. Robotically assisted surgeries with intraoperative ultrasound and visualisation methods as well as vessel-sparing radical retrograde lymphadenectomies for small intestinal NETs seem to be the future of GEP-NET surgery.


  • Open Access

    Minimally invasive versus open surgery for nonfunctioning pancreatic neuroendocrine tumors: a systematic review and meta-analysis

    by Kongyuan Wei, Qingyong Zheng, Luying Cheng, Wei Li, Anna Nießen, Faik G. Uzunoglu, Felix Nickel, Jinhui Tian, Zheng Wang, Thilo Hackert

    Introduction: Nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) have been diagnosed increasingly often but still represent rare pancreatic neoplasms. Surgery is a potentially curative approach for patients with NF-PNETs. In recent years, minimally invasive surgery (MIS) has been applied more frequently for surgical resection of NF-PNETs. The evidence for using MIS for NF-PNETs is still being determined and controversial. Materials and Methods: PubMed, Cochrane Library, and the Web of Science database were searched systematically from its inception to July 2023. All studies comparing MIS versus open surgery (OPS) of NF-PNETs were included. The primary outcomes were the incidence of overall postoperative complications and pancreas-specific complications [postoperative pancreatic fistula (POPF) and delayed gastric emptying (DGE)]. The secondary measures were duration of operation, intraoperative blood loss, and length of postoperative hospital stay. Pooled results are presented as odds ratios (OR) or mean difference (MD) with a 95% CI. Results: Five observational studies with a total of 1178 patients were included in the final analysis. The meta-analysis indicated that MIS attained less intraoperative blood loss (MD=−58.59, 95% CI [−92.76 to −24.41], PPP=0.67), overall postoperative complications (OR=0.78, 95% CI [0.59–1.03], P=0.08), POPF (OR=0.99, 95% CI [0.66–1.47], P=0.94), and DGE (OR=0.58, 95% CI [0.58–1.42], P=0.67). Conclusions: This study demonstrates that minimally invasive surgery for NF-PNETs is safe and associated with a considerably shorter postoperative hospital stay. Further studies are needed to verify the evidence.


  • Portal vein resection in pancreatic neuroendocrine neoplasms

    by Anna Nießen, Ulla Klaiber, Magdalena Lewosinska, Felix Nickel, Franck Billmann, Ulf Hinz, Markus W. Büchler, Thilo Hackert


  • Open Access

    Impact of circumferential resection margin on survival in ampullary cancer: retrospective analysis

    by Anna Nießen, Martin Loos, Katja Neumüller, Manuel Feißt, Ulla Klaiber, Amila Cizmic, Mohammed Al-Saeedi, Susanne Roth, Martin Schneider, Markus W Büchler, et al.

    Ampullary carcinoma is a clinically variable entity. This study aimed to evaluate prognostic factors for the outcome of resected ampullary carcinoma patients with particular intent to analyse the influence of surgical radicality. Patients undergoing resection between 2002 and 2017 were analysed. Clinicopathological parameters, perioperative outcome and survival were examined. Risk factor analysis for postresection survival was performed. Resection margin status was evaluated according to the revised classification for pancreatic adenocarcinoma. A total of 234 patients were identified, 97.9 per cent (n = 229) underwent formal resection, while 2.1 per cent (n = 5) underwent ampullary resection. Histological subtypes were 46.6 per cent (n = 109) pancreatobiliary, 34.2 per cent (n = 80) intestinal, 11.5 per cent (n = 27) mixed, and 7.7 per cent (n = 18) undetermined. In the pancreatobiliary group, tumours were more advanced with more vascular resections, pT4 stage, G3 differentiation and pN+ status. Five-year overall survival was significantly different for pancreatobiliary compared to intestinal (51.7 per cent versus 72.8 per cent, P = 0.0087). In univariable analysis, age, pT4 stage, pN+, pancreatobiliary subtype and positive resection margin were significantly associated with worse overall survival. Long-term outcome was significantly better after true R0 resection (circumferential resection margin–, tumour clearance >1 mm) compared with circumferential resection margin+ (versus 42.4 per cent and 53 months; P = 0.0017). Postresection survival of ampullary carcinoma patients is determined by histological subtype and surgical radicality. Intestinal differentiation is associated with less advanced tumour stages and better differentiation, which is reflected in a significantly better overall survival compared to pancreatobiliary differentiation. Despite this, true R0-resection is a prognostic key determinant in both entities, achieving 5-year survival in two-thirds of patients.


  • Extended Radical Surgery for Pancreatic Cancer

    by Thilo Hackert, Anna Nießen, Markus W. Büchler

  • Open Access

    Management of Recurrence of Cystic Neoplasms

    by Anna Nießen, Christopher L. Wolfgang, Thilo Hackert, Markus W. Büchler